PX
15
2
INTU
69
2
SRE
52
2
GIS
61
-2
NWL
33
11
UA
33
3
GPC
58
-5
ILMN
38
2
ABBV
40
-8
TRIP
75
9
TSCO
66
11
CMG
72
-2
V
66
-2
FOXA
34
-3
ROST
52
2
AMT
41
-4
PRGO
66
9
GPS
52
3
PNR
72
10
AEE
41
-4
PX
15
2
INTU
69
2
SRE
52
2
GIS
61
-2
NWL
33
11
UA
33
3
GPC
58
-5
ILMN
38
2
ABBV
40
-8
TRIP
75
9
TSCO
66
11
CMG
72
-2
V
66
-2
FOXA
34
-3
ROST
52
2
AMT
41
-4
PRGO
66
9
GPS
52
3
PNR
72
10
AEE
41
-4
Financhill
Back

Virtus LifeSci Biotech Clinical Trls ETF Stock Predictions

DeFi Coin Triggers All "Buy" Signals And Could Break Out Soon

Discover our top DeFi pick for potentially massive gains now (before it's too late).
Sell
49

BBC
Virtus LifeSci Biotech Clinical Trls ETF

Last Price:
24.62
Seasonality Move:
4.75%

7 Day Trial

ALL ACCESS PASS

$ 7

7 Powerhouse Stocks to Buy and Hold Forever

Get it now.

Virtus LifeSci Biotech Clinical Trls ETF Stock Forecast

  • Over the next 52 weeks, Virtus LifeSci Biotech Clinical Trls ETF has on average historically risen by 1.8% based on the past 9 years of stock performance.
  • Virtus LifeSci Biotech Clinical Trls ETF has risen higher in 6 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
  • Is Virtus LifeSci Biotech Clinical Trls ETF Stock Undervalued?
    The current Virtus LifeSci Biotech Clinical Trls ETF [BBC] share price is $25.60. The Score for BBC is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • BBC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Virtus LifeSci Biotech Clinical Trls ETF Stock Go Up Next Year?

  • Over the next 52 weeks, Virtus LifeSci Biotech Clinical Trls ETF has on average historically risen by 1.8% based on the past 9 years of stock performance.

Virtus LifeSci Biotech Clinical Trls ETF Stock Rating

Sell
49
Virtus LifeSci Biotech Clinical Trls ETF (BBC) is a Sell

Is Virtus LifeSci Biotech Clinical Trls ETF overpriced?

  • Virtus LifeSci Biotech Clinical Trls ETF has risen higher in 6 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%

Virtus LifeSci Biotech Clinical Trls ETF Stock Price History

Is BBC stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BBC is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NYSEARCA
Country:
Industry:
Sector:
Type:
etf
Website:

52-Week Data

52-Week High:
31.99
52-Week Low:
16.88

Prediction Charts

Market Cap:
0
Price in USD:
25.60
Volume:
3.62K
Beta:
1.30

Technical Analysis

SMA50:
28.24
SMA100:
26.30
SMA200:
23.40
52-Wk Change:
12.02%

Stock Predictions

  • Is Virtus LifeSci Biotech Clinical Trls ETF stock public?
    Yes, Virtus LifeSci Biotech Clinical Trls ETF is a publicly traded company.
  • What is the Virtus LifeSci Biotech Clinical Trls ETF stock quote today?
    The Virtus LifeSci Biotech Clinical Trls ETF stock price is 25.60 USD today.
  • How to buy Virtus LifeSci Biotech Clinical Trls ETF stock online?
    You can buy Virtus LifeSci Biotech Clinical Trls ETF shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-9 27.57 27.86 27.86 27.57
Apr-10 27.11 27.37 27.37 27.11
Apr-11 27.78 28.07 28.10 27.64
Apr-12 27.42 27.12 27.42 27.12
Apr-15 26.91 26.38 26.91 26.31
Apr-16 26.25 26.07 26.26 26.07
Apr-17 26.25 25.74 26.25 25.74
Apr-18 25.48 25.38 25.48 25.38
Apr-19 25.59 24.88 25.59 24.57
Apr-22 24.86 25.17 25.17 24.86
Apr-23 25.67 25.63 25.67 25.63
Apr-24 25.26 25.26 25.26 25.26
Apr-25 24.51 24.70 24.70 24.51
Apr-26 24.69 25.60 25.62 24.69

Virtus LifeSci Biotech Clinical Trls ETF Earnings

Data Unavailable

Virtus LifeSci Biotech Clinical Trls ETF Forecast Revenue Growth

Data Unavailable

* Virtus LifeSci Biotech Clinical Trls ETF stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.